University of Maryland Center of Excellence in Regulatory Science and Innovation

$55,903U01FY2018FDFDA

Univ Of Maryland, College Park, College Park MD

Investigators

Linked publications & trials

Paper 39348508 Paper 38946085 Paper 38600804 Paper 37984065 Paper 37851862 Paper 37555379 Paper 37393691 Paper 37296597 Paper 37205369 Paper 37050893 Paper 36809346 Paper 36685035 Paper 36498497 Paper 36396889 Paper 36251545 Paper 36202250 Paper 35871475 Paper 35830941 Paper 35137300 Paper 35126780 Paper 34756256 Paper 33621099 Paper 33450218 Paper 33301527 Paper 33152375 Paper 33148819 Paper 33058891 Paper 32956678 Paper 32718973 Paper 32713748 Paper 32681061 Paper 32430592 Paper 32380182 Paper 32184277 Paper 31907698 Paper 31696436 Paper 31436536 Paper 30676753 Paper 30361780 Paper 30247920 Paper 30191328 Paper 29345955 Paper 29153870 Paper 29090833 Paper 28442602 Paper 28238947 Paper 25645375 Paper 25448570 Paper 25220493 Paper 25219859 Paper 24328955 Paper 23319170 Paper 22387310 Paper 22339151 Paper 20939504 Paper 20831193 Paper 20807187 Paper 20711748 Paper 20600720 Paper 20599790 Paper 20553862 Paper 20504026 Paper 20496886 Paper 20224985 Paper 19673539 Paper 19557836 Paper 19437106 Paper 19384469 Paper 19085111 Paper 18710255 Paper 18443216 Paper 17367120 Paper 17140262 Paper 16783481 Paper 16749860 Paper 16749855

Abstract

Project Summary: We propose the 5-year renewal of the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), a consortia of the two leading sister campuses within the University System of Maryland, and the FDA. M-CERSI leverages the engineering, device, and technologies strengths in College Park with the biomedical and health outcomes strengths in Baltimore. Five Specific Aims are: 1. Establish Core Program Support and Management Plan to Ensure Success; 2. Grow regulatory science training/educational programs; 3. Build Collaborative Interactions to Foster Regulatory Science Communications Including Scientific Exchanges, Workshops and Seminars; 4. Create New Opportunities for Collaborative Regulatory Science Research; and 5. Create Opportunities to Leverage FDA Funds in Support of CERSI Activities. Pilot research projects are proposed that align UM research strengths with six FDA Regulatory Science Initiatives: o Modernize toxicology to enhance product safety o Support new approaches to improve product manufacturing and quality o Ensure FDA readiness to evaluate innovative emerging technologies o Harness diverse data through information sciences to improve health outcomes o Strengthen social and behavioral science to help consumers and professionals make informed decisions about FDA regulated products o Strengthening the global product safety net In addition to their alignment with FDA-wide priority areas, the pilot projects and other M-CERSI activities align well with priority areas specifically noted by CDER, CBER, CDRH, the OMH, OHI, and OWH. The sum of these activities describe a vibrant, cutting edge Center that stimulates innovative thought, disseminates understanding of regulatory sciences and practices, and generates new knowledge in support of the FDA's fundamental mission ? to promote and protect the public health.

View original record on NIH RePORTER →